ERBB2 and breast cancer: The Notch pathway promotes breast cancer proliferation and invasion by upregulating Hes1 (154, 155), while the STAT3/HIF-1α/Hes1 axis mediates trastuzumab resistance in HER2-positive breast cancer by inhibiting PTEN (100).